Navigation Links
Rat SAP97 Neutralizing Peptide from ABR-Affinity BioReagents

ProductsRat SAP97 Neutralizing Peptide from ABR-Affinity BioReagents
Company ABR-Affinity BioReagents
Item Rat SAP97 Neutralizing Peptide
Price 
Description PEP-055 is a 20 amino acid synthetic peptide whose sequence corresponds to residues 115-133 of rat SAP97. The sequence of this peptide is (amino to carboxy terminus): V115 - L - P - S - E - R - I - S - P - Q - V - P - N - E - V - L - G - P - E133 (C) (The C-terminal cysteine has been added to facilitate conjugation and is not a part of the native rat SAP97 sequence.).
This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and SAP97, catalog # PA1-741. Using a solution of peptide of equal volume and concentration to the corresponding antibody will yield a large molar excess of peptide (~ 70-fold) for competitive inhibition of antibody-protein binding reactions.
Storage: -20 C, Avoid Freeze/Thaw Cycles.
Info ABR-Affinity BioReagentsABR-Affinity BioReagents
ABR-Affinity BioReagents Inc.
4620 Technology Drive, Suite 600
Golden, CO 80403
USA

Customer Service: +1.800.527.4535
Fax Number: +1.303.278.2424
Web Site: http://www.bioreagents.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Human and Mouse RAR Neutralizing Peptide from ABR-Affinity BioReagents
2. Rat rab 3D Neutralizing Peptide from ABR-Affinity BioReagents
3. Rat SCAMP 5 Neutralizing Peptide from ABR-Affinity BioReagents
4. Bovine rhodopsin Neutralizing Peptide from ABR-Affinity BioReagents
5. Human DFF Neutralizing Peptide from ABR-Affinity BioReagents
6. Mouse resistin Neutralizing Peptide from ABR-Affinity BioReagents
7. Rabbit Anti-Human IFN-Alpha / Beta R2 (IFNAR2) (CD118) Neutralizing Polyclonal Antibody, Unconjugated from PBL InterferonSource
8. Mouse Anti-Human IFN-Gamma RC2 (CD118) Non-Neutralizing Monoclonal Antibody, Unconjugated, Clone MMHGR-2 from PBL InterferonSource
9. Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences
10. Peptide Design and Custom Synthesis from Global Peptide Services, LLC.
11. Protein Kinase Substrate (PKS) Peptide Microarray - Comprehensive Service from LC Sciences
(Date:3/18/2016)... --> --> Competitive Landscape ... Vehicles, Physical infrastructure and Perimeter Surveillance & Detection Systems ... market and the continuing migration crisis in the ... has led visiongain to publish this unique report, which is ... & security companies in the border security market and ...
(Date:3/14/2016)... , Allemagne, March 14, 2016 ... ) - --> - Renvoi : image ... --> --> ... biométriques, fournit de nouveaux lecteurs d,empreintes digitales pour ... de DERMALOG sera utilisé pour produire des cartes ...
(Date:3/9/2016)... -- This BCC Research report provides an overview of ... (RNA Seq) market for the years 2015, 2016 and ... data analysis, and services. Use this report ... such as RNA-Sequencing tools and reagents, RNA-Sequencing data analysis, ... segment and forecast their market growth, future trends and ...
Breaking Biology News(10 mins):
(Date:4/26/2016)... ... April 27, 2016 , ... Cameron ... LLP as an associate in the firm’s Intellectual Property practice group. , Clients ... electromechanical patent applications. He has an electrical engineering and computer engineering background, and ...
(Date:4/26/2016)... ... April 26, 2016 , ... The European Patent ... selected as one of three finalists for the European Inventor Award 2016 in the ... prize will be announced at a ceremony in Lisbon on June 9th. , The ...
(Date:4/26/2016)... ... April 26, 2016 , ... Mr. Palmer created the RPO business ... first multi-million dollar, multi-year managed services contract in the U.S. intelligence community with The ... leadership team,” said John Younger, founder of Accolo. “We are growing and his ...
(Date:4/26/2016)... ... 26, 2016 , ... BioFactura, Inc ., a biopharmaceutical research and manufacturing ... Healthy investor interest drove significant oversubscription of the original $1.5M target. The funds ... the advanced preclinical stages. , Chief Executive Officer and President, Darryl Sampey ...
Breaking Biology Technology: